Development of ZEPATIER®-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of ZEPATIER®

Published:2019 Issue: Volume: Page:369-407
ISSN:1862-2461
Container-title:Topics in Medicinal Chemistry
language:
Short-container-title:

Author:

Robertson Michael N.,Barr Eliav

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/7355_2018_54

Reference36 articles.

1. Coburn C (2018) Discovery of elbasvir. Top Med Chem. https://doi.org/10.1007/7355_2018_44

2. McCauley J, Rudd M (2018) The invention of grazoprevir: an HCV NS3/4a protease inhibitor. Top Med Chem. https://doi.org/10.1007/7355_2018_41

3. Lahser FC, Bystol K, Curry S, McMonagle P, Xia E, Ingravallo P et al (2016) The combination of grazoprevir, a hepatitis C virus (HCV) NS3/4A protease inhibitor, and elbasvir, an HCV NS5A inhibitor, demonstrates a high genetic barrier to resistance in HCV genotype 1a replicons. Antimicrob Agents Chemother 60(5):2954–2964

4. Harper S, McCauley JA, Rudd MT, Ferrara M, DiFilippo M, Crescenzi B et al (2012) Discovery of MK-5172, a macrocyclic hepatitis C virus NS3/4a protease inhibitor. ACS Med Chem Lett 3(4):332–336

5. Summa V, Ludmerer SW, McCauley JA, Fandozzi C, Burlein C, Claudio G et al (2012) MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants. Antimicrob Agents Chemother 56(8):4161–4167

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curing Hepatitis C with Direct‐Acting Antiviral Therapy;New Drug Development for Known and Emerging Viruses;2021-12-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3